Berenberg analyst Harry Gillis lowered the firm’s price target on Qiagen (QGEN) to EUR 46 from EUR 50 and keeps a Buy rating on the shares.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QGEN:
- Qiagen price target lowered to $48 from $50 at TD Cowen
- Qiagen’s Hold Rating: Solid Q3 Performance Overshadowed by Uncertainties and Mixed Growth Outlook
- Qiagen’s Hold Rating: Navigating Market Crosswinds and Valuation Concerns
- Qiagen price target lowered to $46 from $49 at Baird
- QIAGEN Announces Q3 Results, Parse Acquisition, and Share Repurchase